Read More Pharma Industry News Can UPLIZNA transform gMG treatment? Amgen’s FDA win sets new benchmark for antibody-positive patients Discover how Amgen’s UPLIZNA is redefining generalized myasthenia gravis treatment after FDA approval. Find out what this means for patients and investors. bySrinathDecember 12, 2025